TABLE 4.
Details of the Expressive Writing Studies Reviewed
| Authors | Study Year | Study Design | No. of Participants | Study Population | Variables Measured | Findings |
| Petrie et al.83 | 2004 | Randomized controlled trial (emotional or control topics) | 37 | HIV patients | CD4+ lymphocyte count and viral load | Postintervention improvements CD4+ lymphocyte counts |
| Graham et al.84 | 2008 | Randomized controlled trial (anger expression or writing about goals nonemotionally) | 102 | Chronic illness patients | Letter writing on 2 occasions, coded for degree of expressed anger and meaning making | Improvements in anger expression group in control over pain, depressed mood, and pain severity |
| Junghaenel et al.85 | 2008 | Randomized controlled trial (emotional disclosure, neutral, or usual care) | 92 | Fibromyalgia patients | Pain, well-being, fatigue | Improvements in interpersonally distressed group in psychological well-being, pain, and fatigue. |
| Gillis et al.86 | 2006 | Randomized controlled trial (4 days of writing at home and control) | 72 | Fibromyalgia patients | At-home written emotional disclosure; mood effects and changes in health from baseline to 1 month and 3 months | Immediate improvements in written disclosure group in negative mood; at 1 month, disclosure led to few health benefits; at 3 months, negative mood and social support effects disappeared, and written disclosure decreased poor sleep, health care use, and physical disability |
| Broderick et al.87 | 2005 | Randomized controlled trial (trauma writing, control writing, usual care) | 92 | Fibromyalgia patients | Quality of life, anxiety, depression, pain, fibromyalgia | Trauma writing decreased pain, fatigue, and psychological well-being at 4 months; benefits were not maintained at 10 months |